Extravasation Injuries: Current Medical and Surgical Treatment

References

• Schrijvers D. L. Extravasation: a dreaded complication. Ann Oncol, 2003, 14: iii26–30.
   Google Scholar
• Lynch D. J., Key J. C., White R. R. Management and prevention of infiltration and extravasation injury. Surg Clin North Am, 1979, 59: 939–949.
   Google Scholar
• Upon J., Mulliken J. B., Murray J. E. Major intravenous extravasation injuries. Am J Surg, 1979, 137: 497–506.
   Google Scholar
• Yosowitz P., Ekland D. A., Shaw R. C., Parsons R. W. Peripheral intravenous infiltration necrosis. Ann Surg, 1975, 182: 553–556.
   Google Scholar
• Gault D. T. Extravasation injuries. Br J Plast Surg, 1993, 46: 9196.
   Google Scholar
• Dorr R. T. Antidotes to vesicant chemotherapy extravasations. Blood Rev, 1990, 4: 41–60.
   Google Scholar
• Bertelli G. Prevention and management of ectravasation of cytotoxic drugs. Drug Safety, 1995, 12: 245–255.
   Google Scholar
• Schneider S. M., Distelhorst C. W. Chemotherapy-induced emergencies. Semin Oncol, 1989, 16: 572–578.
   Google Scholar
• Dorr R. T. Pharmacologic management of vesicant chemotherapy extravasations. In: Dorr R. T., Von Hoff D. D. (eds.). Cancer chemotherapy Handbook, 2nd edition. Norwalk, CT: Appleton and Lange, 1993, 109–118.
   Google Scholar
• Hahn J. C., Shafritz A. B. Chemotherapy extravasation injuries. J Hand Surg, 2012, 37A: 360–362.
   Google Scholar
• Schaverien M. v., Demetrius E., McCulley S. J. Management of large volume CT contrast medium extravasation injury: technical refinement and literature review. J Plast Recon Aesth Surg, 2008, 61: 562–565.
   Google Scholar
• De Souza B. A., Shibu M. Painless acyclovir extravasation injury in a diabetic. Br J Plast Surg, 2002, 55: 264.
   Google Scholar
• Robbins M. S., Stromquist C., Tan L. H. Acyclovir pH - possible cause of extravasation tissue injury. Ann Pharmacother, 1993, 27: 238.
   Google Scholar
• Ener R. A., Meglathery S. B., Styler M. Extravasation of systemic hemato-oncological therapies. Ann Oncol, 2004, 15: 858862.
   Google Scholar
• Jordan K., Grothe W., Schmoll H.-J. Paravasation von Zytostatika: Prävention und Therapie. Dtsch Med Wochenschr, 2005, 130: 33–37.
   Google Scholar
• Mader I., Fürst-Weger P., Mader R. M. et al. Paravasation von Zytostatika. Springer Wien New York, 2002.
   Google Scholar
• Kumar R. J., Pegg S. P., Kimble R. M. Management of extravasation injuries. ANZ J Surg, 2001, 71: 285–289.
   Google Scholar
• Huijbers E. J., Baars J. W., Schutte P. F., Schellens J. H., Beijnen J. H. Propofol extravasation in a breast cancer patient. J Oncol Pharm Pract, 2008, 14: 195–198.
   Google Scholar
• Mahajan R., Gupta R., Sharma A. Extravasation injury caused by propofol. Anesth Analg, 2006, 102: 648.
   Google Scholar
• Ohnoshi T., Ohnuma T., Beranek J. T. et al. Combined effects of hyperthermia and anthracycline antibiotics on human tumor cells. J Natl Cancer Inst, 1985, 74: 275–281.
   Google Scholar
• Harwood K. v., Bachur N. Evaluation of dimethyl sulfoxide and local cooling as antidotes for doxorubicin extravasation in a pig model. Oncol Nurs forum, 1987, 14: 39–44.
   Google Scholar
• Rudolf R., Larson D. Etiology and treatment of chemotherapeu-tic agent extravasation injuries: a review. J Clin Oncol, 1987, 5: 1116–1126.
   Google Scholar
• Dorr R. T. Pharmacologic management of vesicant chemotherapy extravasations. In: Dorr RT, vonn Hoff DD (eds): Cancer Chemotherapy Handbook, 2nd edition. Norwalk, CT: Appleton & Lange, 1993: 109–118.
   Google Scholar
• Dorr R. T., Albert D. S. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse. J Natl Cancer Inst, 1985, 74: 113–120.
   Google Scholar
• Svingen B. A., Powis G., Appel P. L., Scott M. Protection against adriamycin-induced skin necrosis in the rat by dimethyl sulfoxide and [tocopherol. Cancer Res, 1981, 41: 3395–3399.
   Google Scholar
• Desai M. H., Teres D. Prevention of doxorubicin-induced skin ulcers in the rat and pig with dimethyl-sulfoxide (DMSO). Cancer Treat Rep, 1982, 66: 1371–1374.
   Google Scholar
• Bertelli G., Gozza A., Dini D. et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: A prospective clinical study. J Clin Oncol, 1995, 13: 2851–2855.
   Google Scholar
• Olver I. N., Aisner J., Hament A., Buchanan L., Bishop J. F., Kaplan R. S. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol, 1988, 11: 1732–1735.
   Google Scholar
• Lawrence H. J., Walsh D., zapotowski K. A., Denham A., Goodnight S. H., Gandara D. R. Topical dimethylsulfoxide may prevent tissue damage from anthracycline extravasation. Cancer Chemother Pharmacol, 1989, 23: 316–318.
   Google Scholar
• Langer S. W., Thougaard A. V., Schested M., Jensen P. B. Treatment of anthracycline extravasation in mice with dexrazox-ane with or without DMSO and hydrocortisone. Cancer Chemother Pharmacol, 2006, 57: 125–128.
   Google Scholar
• Dorr R. T., Alberts D. S. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse. Cancer Treat Rep, 1982, 66: 1371–1374.
   Google Scholar
• Alberts D. S., Dorr R. T. Case Report: Topical DMSO for mitomycin C-induced skin ulceration. Oncol Nurs Forum, 1991, 18: 693–695.
   Google Scholar
• Dorr R. T., Alberts D. S. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse. J Natl Cancer Inst, 1985, 74: 113–120.
   Google Scholar
• Spugnini E. P Use of hyaluronidase for the treatment of extravasation of chemotherapeutic agents in six dogs. J Am Vet Med Assoc, 2002, 2212: 1437–1440, 1419–1420.
   Google Scholar
• Kumar M. M., Sprung j. The use of haluronidase to treat mannitol extravasation. Anesth Analg, 2003, 97: 1199–1200.
   Google Scholar
• Bertelli G., Dini D., Pronzato P. et al. Hyaluronidase as an antidote to extravasation of vinca alkaloids: clinical results. J Cancer Res Clin Oncol, 1994, 120: 505–506.
   Google Scholar
• Laurie S. W., Wilson K. L., Kernahan D. A., Bauer B. S., Vistness L. M. Intravenous extravasation injuries: the effectiveness of hyaluronidase in their treatment. Ann Plast Surg, 1984, 13: 191–194.
   Google Scholar
• TamuraY., Ikeda O., NakasoneY., Iryo Y., Yamashita Y. Effect of sodium thiosulfate on cisplatin removal after intra-arterial embolization with a lipiodol-platinum suspension for hepato-cellular carcinoma. Acta Radiol, 2010 Epub ahead of print.
   Google Scholar
• Dorr R. T., Soble M., Alberts D. S. Efficacy of sodium thio-sulfate as a local antidote to mechlorethamine skin toxicity in the mouse. Cancer Chem-other Pharmacol, 1988, 22: 299–302.
   Google Scholar
• Howell S. B., Taetle R. Effect of sodium thiosulfate on cis-dichloro-diammineplatinum(II)toxicity and antitumor activity in L1210 leukemia. Cancer Treatment Rep, 1980, 64: 611–616.
   Google Scholar
• Dorr R. Antidotes to vesicant chemotherapy extravasations. Blood Rev, 1990, 4: 41–60.
   Google Scholar
• Langer S. W., Schested M., Jensen P. B. Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice. Ann Oncol, 2001, 12: 405–410.
   Google Scholar
• Langer S. W., Thougaard A. V., Jensen P. B. Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane. Clin Cancer Res, 2012, 69: 573576.
   Google Scholar
• Langer S. W., Schested M., Jensen P. B. Treatment of anthracycline extravasation with dexrazoxane. Clin Cancer Res, 2006, 6: 3680–3686.
   Google Scholar
• Fontaine C., Noens L., De Grève J. Savene® (dexrazoxane) use in clinical practice. Supp Care Canc, 2012, 20: 1109–1112.
   Google Scholar
• Mouridsen H. T., Langer S. W., Giaccone G. et al. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann Oncol, 2007, 18: 546–550.
   Google Scholar
• SUBHANI M., Sridhar S., DeCristofaro J. D. Phentolamine use in the neonate for the prevention of dermal necrosis caused by dopamine: a case report. J Perinatol, 2001, 21: 324–326.
   Google Scholar
• Hill J. M. Phentolamine mesylate: the antidote for vasopressor extravasation. Crit Care Nurse, 1991, 11: 58–61.
   Google Scholar
• Maguire W. M., Reisdorf E. J., Smith D., Wiegenstein J. G. Epinephrin-induced vasospasm reversed by phentolamine digital block. Am J Emerg Med, 1990, 8: 46–47.
   Google Scholar
• Bey D., El-Chaar G. M., Bierman F., Valderrama E. The use of phentolamine in the prevention of dopamine-induced tissue extravasation. J Crit Care, 1998, 13: 13–20.
   Google Scholar
• Vanwijck R. Liposuction to radiologist’s rescue. Plast Reconstr Surg, 1993, 92: 175.
   Google Scholar
• Vandeweyer E., Heymans O., Deraemaecker R. Extravasation injuries and emergency suction as treatment. Plast Reconstr Surg, 2000, 105: 109–110 .
   Google Scholar
• Von Heimburg D., Pallua N. Früh-und Spätbehandlung iatrogen-er injektionsschäden. Chirurg, 1998, 69: 1378–1382.
   Google Scholar
• Telisselis P, Heers G., Plock B., Baier C., Neugebauer R., FüCHTMEiER B. Sofortige offene chirurgische behandlung von zyto-statika-paravasaten der oberen extremität. Handchir Mikrochir Plast Chir, 2009, DOI 10.1055/s-0029-1241185.
   Google Scholar
• Disa J. J., Chang R. R., Mucci S. J., Goldberg N. H. Prevention of Adriamycin-induced full-thickness skin loss using hyaluronidase infiltration. Plast Reconstr Surg, 1998, 101: 307.
   Google Scholar
• Rudolph R., Suzuki M., Luce J. K. Experimental skin necrosis produced by adriamycin. Cancer Treat Rep, 1979, 63: 529.
   Google Scholar
• Yilmaz M., Demirdover G., Mola F. Treatment options in extravasation injury: an experimental study in rats. Plast Reconstr Surg, 2002, 109: 2418–2424.
   Google Scholar
• Andersson A. P., Dahlstrom K. K. Clinical results after doxoru-bicin extravasation treated with excision guided by fluorescence microscopy. Eur J Cancer, 1993, 29A: 1712–1714.
   Google Scholar
• Dahlstrom K. K., Chenoufi H. L., Daugaard S. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Experimental and clinical studies. Cancer, 1990, 65: 1722–1726.
   Google Scholar